首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Analysis of antibody-drug conjugates by comprehensive on-line two-dimensional hydrophobic interaction chromatography x reversed phase liquid chromatography hyphenated to high resolution mass spectrometry. II- Identification of sub-units for the characterization of even and odd load drug species
【24h】

Analysis of antibody-drug conjugates by comprehensive on-line two-dimensional hydrophobic interaction chromatography x reversed phase liquid chromatography hyphenated to high resolution mass spectrometry. II- Identification of sub-units for the characterization of even and odd load drug species

机译:通过高分辨率的质谱联用的综合在线二维疏水相互作用色谱x反相液相色谱分析抗体-药物偶联物。 II-鉴定用于偶数和奇数负载药物种类表征的亚单位

获取原文
获取原文并翻译 | 示例
       

摘要

This paper is the second part of a two-part series dedicated to the development of an on-line comprehensive HICxRPLC-UV/MS method for the characterization of a commercial inter-chain cysteine-linked ADC (brentuximab vedotin, Adcetris (R)). The first part focused on the optimization of the chromatographic conditions. In the second part of this series of papers, the structural characterization of the Brentuximab Vedotin was extensively discussed. With the combination of HIC and RPLC-MS data, the average DAR was easily measured in HIC and, at the same time, the predominant positional isomers were identified in RPLC-MS in one single injection. it was also demonstrated that the retention data obtained in the first and second dimensions was particularly useful to assist ADC characterization through the identification of sub-units. Using this methodology, the presence of odd DARs (1,3 and 5) arid their relative abundance was assessed by a systematic evaluation of HIC x RPLC-UV/MS data for both commercial and stressed ADC samples. Finally, once the exhaustive characterization of ADC was completed, MS could be conveniently replaced by UV detection to quickly assess the conformity of different ADCs batches. (C) 2016 Elsevier B.V. All rights reserved.
机译:本文是由两部分组成的系列文章的第二部分,该系列文章致力于开发在线综合HICxRPLC-UV / MS方法,以表征商业链间半胱氨酸连接的ADC(brentuximab vedotin,Adcetris(R)) 。第一部分着重于色谱条件的优化。在本系列文章的第二部分中,广泛讨论了Brentuximab Vedotin的结构表征。结合HIC和RPLC-MS数据,可以很容易地在HIC中测量平均DAR,并且一次可以在RPLC-MS中鉴定出主要的位置异构体。还证明了在第一维和第二维中获得的保留数据对于通过识别亚单位来辅助ADC表征特别有用。使用这种方法,通过对商业和压力ADC样品的HIC x RPLC-UV / MS数据进行系统评估,评估了奇数DAR(1、3和5)及其相对丰度的存在。最后,一旦完成了ADC的详尽表征,便可以通过UV检测方便地替换MS,以快速评估不同ADC批次的一致性。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号